A peptide reconstituted in 0.9% saline lacks the preservative needed for multi-dose use, and the peptide will typically aggregate within 3-5 days of regular re-puncture
Namkoong J, Shin SS, Lee HJ, Marn YE, Wall BA, Goydos JS, et al
They also flag uncertainties and contextual guesses, ensuring the process is transparent and trustworthy
A 2023 review in the Journal of Clinical Endocrinology & Metabolism highlighted that GLP-1s can delay gastric emptying significantly, especially at higher doses or early in treatment.44 Another study found that just over 5% of patients experience gastroparesis and it was more likely when using liraglutide or dulaglutide when compared with semaglutide.45 A 2024 cross-sectional analysis in Pharmaceuticals examined the GI side effects of semaglutide, dulaglutide, liraglutide, and exenatide in over 10,000 adults with T2DM or obesity from the National Institutes of Health All of Us cohort.45 They found that abdominal pain was the most frequently reported GI issue (57.6%), followed by constipation, diarrhea, nausea/vomiting, GI bleeding, gastroparesis, and pancreatitis
Were here to answer your questions and address any concerns you may have